Envestnet Asset Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-34,825
| Closed | -$1.61M | – | 3219 |
|
|
2019
Q2 | $1.61M | Sell |
34,825
-28,858
| -45% | -$810K | ﹤0.01% | 1684 |
|
|
2019
Q1 | $1.55M | Buy |
63,683
+25,239
| +66% | +$525K | ﹤0.01% | 1617 |
|
|
2018
Q4 | $548K | Buy |
+38,444
| New | +$583K | ﹤0.01% | 2093 |
|
|
2018
Q1 | – | Sell |
-269
| Closed | -$3K | – | 3022 |
|
|
2017
Q4 | $3K | Sell |
269
-498
| -65% | -$5.66K | ﹤0.01% | 2816 |
|
|
2017
Q3 | $9K | Hold |
767
| – | – | ﹤0.01% | 2625 |
|
|
2017
Q2 | $6K | Hold |
767
| – | – | ﹤0.01% | 2813 |
|
|
2017
Q1 | $7K | Sell |
767
-3
| -0.4% | -$32 | ﹤0.01% | 2856 |
|
|
2016
Q4 | $6K | Buy |
+770
| New | +$5.67K | ﹤0.01% | 2864 |
|
|
2016
Q2 | – | Sell |
-1,050
| Closed | -$3K | – | 3176 |
|
|
2016
Q1 | $3K | Buy |
+1,050
| New | +$3.15K | ﹤0.01% | 3064 |
|
|
2015
Q4 | – | Sell |
-1,053
| Closed | -$5K | – | 3115 |
|
|
2015
Q3 | $5K | Buy |
+1,053
| New | +$6.24K | ﹤0.01% | 3028 |
|
|
2015
Q1 | – | Sell |
-1,384
| Closed | -$7K | – | 2550 |
|
|
2014
Q4 | $7K | Sell |
1,384
-176
| -11% | -$696 | ﹤0.01% | 2065 |
|
|
2014
Q3 | $6K | Hold |
1,560
| – | – | ﹤0.01% | 2272 |
|
|
2014
Q2 | $7K | Sell |
1,560
-118
| -7% | -$488 | ﹤0.01% | 2194 |
|
|
2014
Q1 | $8K | Hold |
1,678
| – | – | ﹤0.01% | 1987 |
|
|
2013
Q4 | $8K | Sell |
1,678
-33
| -2% | -$180 | ﹤0.01% | 1856 |
|
|
2013
Q3 | $11K | Buy |
+1,711
| New | +$10.2K | ﹤0.01% | 1689 |
|
Other funds holding ARRY
Envestnet Asset Management's ARRY Position: Q3 2019 in Review
Envestnet Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 34,825 shares — an estimated $1.61M sold.
Envestnet Asset Management first reported a position in ARRY in Q3 2013 and held it in 16 quarters. The position peaked at $1.61M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Envestnet Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Envestnet Asset Management sold 34,825 Array Biopharma Inc shares in Q3 2019, an estimated $1.61M.
- Envestnet Asset Management first reported a position in Array Biopharma Inc in Q3 2013 and held it in 16 quarters.
- Envestnet Asset Management's Array Biopharma Inc position peaked at $1.61M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Envestnet Asset Management's 13F filing for Q3 2019, filed 17 Oct 2019.